This brand name is authorized in Austria, Australia, Brazil, Cyprus, Spain, Finland, France, Hong Kong, Ireland, Netherlands, New Zealand, Poland, Singapore, Tunisia, United Kingdom, South Africa
The drug OXYNORM contains one active pharmaceutical ingredient (API):
|
1
Oxycodone
UNII C1ENJ2TE6C - OXYCODONE HYDROCHLORIDE
|
|
Oxycodone is a full opioid agonist with no antagonist properties. It has an affinity for kappa, mu and delta opioid receptors in the brain and spinal cord. Oxycodone is similar to morphine in its action. The therapeutic effect is mainly analgesic, anxiolytic, antitussive and sedative. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| OXYNORM Concentrate oral solution | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| OXYNORM Capsule, hard | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| OXYNORM 10 mg/ml Solution for injection or infusion | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N02AA05 | Oxycodone | N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 12031F, 12074L, 12311Y, 12314D, 5190E, 5191F, 5197M, 8464L, 8501K, 8502L, 8644Y |
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 556721030004905, 556721030005005 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 66574, 66575, 66576, 66614, 71243 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 003449, 003485, 004795, 005068, 005088, 006244, 006255, 006263, 022119 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 60209645, 60629186, 61007415, 61115864, 61613434, 65821685, 66268312, 67565715, 68127381 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 155455, 162207, 162209, 162211, 186052, 186054, 28958, 28961, 28964, 28976, 28984, 376967, 376969, 376971, 381590, 46355, 46361 |
| Country: HK | Department of Health Drug Office | Identifier(s): 59575, 59576, 59577, 61835, 66357, 66358 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 38149, 38162, 38174, 38196, 38239, 38546, 38710, 59007, 59017, 59024, 59073 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 14903547, 14930978 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 68209, 68217, 68225, 70726, 72761, 94374, 94390, 94412 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 11876, 12258, 13456, 9550, 9551, 9552 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100206840 |
| Country: SG | Health Sciences Authority | Identifier(s): 13079P, 13081P, 13083P, 13733P, 14125P, 14126P |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 16263021, 16263022, 16263023 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 41/2.9/1103, 41/2.9/1104, 41/2.9/1105, 46/2.9/0718, 46/2.9/0719 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
